All it takes is one top drug.
News & Analysis: Dova Pharmaceuticals, Inc.
Earnings and other good news helped these stocks climb.
Stockholm-based Sobi wants to expand its U.S. presence, beginning with Dova's platelet therapy.
DOVA earnings call for the period ending June 30, 2019.
It was a great week for these three stocks, but can they continue climbing?
The drugmaker's Doptelet therapy just received an expanded approval.
DOVA earnings call for the period ending March 31, 2019.
DOVA earnings call for the period ending December 31, 2018.
A tough market and bad news sent these stocks sharply lower.
Traders flee in response to a surprise management shake-up and weak financial guidance.